𝔖 Bobbio Scriptorium

✦ LIBER ✦

Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab

✍ Scribed by M. Herold; G. Dölken; F. Fiedler; A. Franke; M. Freund; W. Helbig; R. Pasold

Publisher: Springer
Year: 2003
Tongue: English
Weight: 131 KB
Volume: 82
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-002-0581-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bendamustine, vincristine and prednisone

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

✍ M. Herold; A. Schulze; D. Niederwieser; A. Franke; H. J. Fricke; P. Richter; M. 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 313 KB

Randomized open label phase III trial of

Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multi- center trial by the Austrian Working Group For Medical Tumor Therapy

✍ M. A. Fridrik; R. Greil; H. Hausmaninger; O. Krieger; P. Oppitz; M. Stöger; J. K 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 174 KB